Cantor Fitzgerald raised the firm’s price target on Phathom Pharmaceuticals (PHAT) to $29 from $23 and keeps an Overweight rating on the shares.

Cantor Fitzgerald’s latest Bi-Weekly Trading Report paints a cautiously defensive outlook for the equities market over the ...

Cantor Fitzgerald analysts increased the price target for Etsy, Inc. (NASDAQ:ETSY) from $47 to $52 and kept a “Neutral” ...

Cantor Fitzgerald, a financial services firm, that it entered into a definitive agreement to acquire UBS’s O’Connor ...

The Cantor Fitzgerald Gold Protected Bitcoin Fund, which the firm said will be its first BTC-focused investment vehicle, is ...

Cantor Fitzgerald LP agreed to buy UBS Group AG’s O’Connor unit, ending more than three decades of ownership by the Swiss ...

Financial services company Cantor Fitzgerald has signed a definitive agreement to purchase UBS's O’Connor alternatives ...

UBS' arm is set to sell its $11B O'Connor unit to Cantor Fitzgerald, sharpening its focus post-Credit Suisse merger amid ...

Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.

Cantor Fitzgerald’s gold-backed Bitcoin fund may attract billions in cautious capital, stabilizing BTC while institutional ...

U.S. brokerage firm Cantor Fitzgerald has agreed to buy UBS' hedge fund unit, it was announced on Wednesday, expanding Cantor ...

Cantor Fitzgerald is debuting a new gold-backed Bitcoin fund for investors scared of the cryptocurrency's volatility.